Dear Doctor Letter (Rote-Hand-Brief) on medicinal products containing bromocriptine: Restrictions of indication regarding inhibition of lactation
2014.12.04
Active substance: bromocriptine
The marketing authorisation holders of medicinal products containing bromocriptine are circulating information that bromocriptine should only be taken in strengths up to 2.5 mg per individual dose for prevention or inhibition of lactation after childbirth, if medically indicated, e.g. in the case of intrapartum loss, neonatal death or HIV infection of the mother.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN